A pilot, randomised placebo-controlled study of cognitive enhancer and cognitive training combination: testing a therapeutic paradigm for cognitive impairment in schizophrenia.

Trial Profile

A pilot, randomised placebo-controlled study of cognitive enhancer and cognitive training combination: testing a therapeutic paradigm for cognitive impairment in schizophrenia.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Mar 2015

At a glance

  • Drugs Modafinil (Primary)
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Acronyms ModCTCoS
  • Most Recent Events

    • 01 Dec 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 19 Mar 2012 European Clinical Trials Database record reports planned end date is 23 Mar 2011.
    • 23 Feb 2012 Planned end date (1 Dec 2012) added as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top